![]() |
市場調査レポート
商品コード
1754012
眼科用レーザー市場レポート:製品、適応症、エンドユーザー、地域別、2025年~2033年Ophthalmic Lasers Market Report by Product, Indication, End-User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
眼科用レーザー市場レポート:製品、適応症、エンドユーザー、地域別、2025年~2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
|
世界の眼科用レーザー市場規模は2024年に13億2,000万米ドルに達しました。今後、IMARC Groupは、市場は2033年には19億4,000万米ドルに達し、2025-2033年の成長率(CAGR)は4.15%になると予測しています。低侵襲手術の需要増加、白内障手術へのフェムトセカンドレーザの採用拡大、眼科疾患の有病率上昇は、市場成長を促進する主な要因の一つです。
眼疾患の有病率の増加
視力関連疾患の増加が主に市場の成長を牽引しています。例えば、WHO 2021によると、世界中で少なくとも22億人が近視または遠視の障害を持っています。WHOはまた、視力障害は矯正されていない近視(2,440億米ドル)と老眼(254億米ドル)による視力障害に関連した世界の経済的負担をもたらすと述べています。2022年1月、世界経済フォーラムのプレスリリースによると、近視(近視)の割合が大幅に上昇しました。2050年までに、世界人口の半数が近視になるとさえ予測されています。さらに、世界保健機関(WHO)が2021年10月に発表したプレスリリースによると、約8,840万人が未対処の屈折異常により失明しています。これに加えて、眼障害を開発しやすい老年人口が世界中で増加していることが、眼科用レーザー市場の需要をさらに刺激しています。例えば、現在米国には65歳以上の成人が約6,200万人おり、人口の18%を占めています。2054年には、65歳以上の成人は8,400万人に達し、人口の23%を占めると推定されます。
技術の進歩
レーザー技術、特に精度、スピード、安全性といった分野における継続的な進歩が、様々な眼疾患に対する眼科用レーザーの採用を促進しています。さらに、レーシック、白内障手術、角膜移植などの精密で低侵襲な手術へのフェムトセカンドレーザー技術の採用が増加しており、市場全体に有利な成長機会をもたらしています。これに伴い、さまざまな主要市場企業が診断、治療計画、個別化された患者ケアを強化する先進技術を搭載した眼科用レーザーを発売しています。例えば、2022年4月、Nova Eye Medical社は次世代管腔形成装置iTrack Advanceを欧州とアジア太平洋で発売しました。iTrack Advanceの特徴は、オリジナルのiTrack装置の先端部に独自の照明付き光ファイバーを搭載し、外科医がシュレム管内の装置の位置を継続的にモニターできるようにしたことです。同様に、ルミバード・グループは同月、同年にCapsulo Nd:YAGレーザーを発売しました。この装置は完全に統合された汎用性の高いレーザープラットフォームとして設計されており、効率的で正確な被膜切開と虹彩切開の治療を可能にします。このような取り組みが、今後数年間の眼科用レーザー市場の収益を促進すると予想されます。
従来の視力矯正にとどまらない製品用途の拡大
糖尿病網膜症、加齢黄斑変性症(AMD)、網膜静脈閉塞症などの網膜疾患の治療など、従来の視力矯正以外の眼科用レーザーアプリケーションの多様化も、眼科用レーザーの世界市場の成長を促進しています。糖尿病性網膜症では、レーザー光凝固術が一般的に使用され、漏れた血管を塞いだり、視力低下の原因となる異常な血管を破壊したりします。さらに、糖尿病性網膜症の症例の増加が眼科用レーザー市場シェアを押し上げています。例えば、IMARCによると、世界の糖尿病網膜症市場規模は2023年に81億米ドルに達しました。今後、IMARC Groupは、同市場が2032年までに130億米ドルに達し、2024年から2032年にかけて5.2%の成長率(CAGR)を示すと予測しています。同様に、AMDにおける眼科用レーザーの利用が拡大し、異常な血管を標的にして封鎖することで、さらなる視力悪化のリスクを低減することも、市場の成長に寄与しています。例えば、2020年8月にBritish Journal of Ophthalmologyに掲載された調査論文によると、欧州では加齢黄斑変性(AMD)が視覚障害や失明の主な原因となっています。欧州では約6,700万人が加齢黄斑変性(AMD)の影響を受けています。眼科用レーザーの市場予測によると、網膜障害の患者数の増加は市場成長に正比例しています。
The global ophthalmic lasers market size reached USD 1.32 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1.94 Billion by 2033, exhibiting a growth rate (CAGR) of 4.15% during 2025-2033. Increasing demand for minimally invasive procedures, growing adoption of femtosecond lasers for cataract surgery, and rising prevalence of ophthalmic disorders are some of the key factors driving the market growth.
Increasing Prevalence of Eye Disorders
The increasing cases of vision-related disorders are primarily driving the growth of the market. For instance, according to the WHO 2021, at least 2.2 billion people had near or distant vision impairment across the globe. WHO also stated that vision impairment poses a global financial burden associated with vision impairment from uncorrected myopia (US$ 244 Billion) and presbyopia (US$ 25.4 billion). In January 2022, a press release by the World Economic Forum indicated that rates of short-sightedness (myopia) rose significantly. By 2050, it's even predicted that half of the world's population will be short-sighted. Moreover, according to the October 2021 press release by the World Health Organization, approximately 88.4 million people suffered blindness due to unaddressed refractive errors. Besides this, the rising geriatric population across the globe, who are more prone to developing eye disorders, is further catalyzing the ophthalmic lasers market demand. For instance, there are currently roughly 62 million adults aged 65 and older living in the U.S., accounting for 18% of the population. By 2054, 84 million adults aged 65 and older will make up an estimated 23% of the population.
Technological Advancements
Ongoing advancements in laser technology, particularly in areas such as precision, speed, and safety, are driving the adoption of ophthalmic lasers for various eye conditions. Moreover, the increasing adoption of femtosecond laser technology for precise and minimally invasive procedures such as LASIK, cataract surgery, and corneal transplantation is offering lucrative growth opportunities to the overall market. In line with this, various key market players are launching ophthalmic lasers with advanced technologies for enhanced diagnostics, treatment planning, and personalized patient care. For instance, in April 2022, Nova Eye Medical launched its next-generation canaloplasty device, iTrack Advance, in Europe and Asia-Pacific. The iTrack Advance features include a proprietary illuminated fiber optic tip of the original iTrack device to allow the surgeon to continuously monitor the location of the device in Schlemm's canal. Similarly, in the same month and year, Lumibird Group launched the Capsulo Nd: YAG laser. The device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments. Thus, such initiatives are expected to propel the ophthalmic lasers market revenue in the coming years.
Expanding Product Application Beyond Traditional Vision Correction
The diversification of ophthalmic laser applications beyond traditional vision correction, including treatment of retinal disorder, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vein occlusion, is also catalyzing the growth of the global ophthalmic lasers market. In diabetic retinopathy, laser photocoagulation is commonly used to seal leaking blood vessels or to destroy abnormal blood vessels that may be causing vision loss. Moreover, the rising cases of diabetic retinopathy are propelling the ophthalmic lasers market share. For instance, according to IMARC, the global diabetic retinopathy market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. Similarly, the escalating utilization of ophthalmic lasers in AMD to target and seal abnormal blood vessels, reducing the risk of further vision deterioration, is also contributing to the market growth. For instance, according to a research article published in the British Journal of Ophthalmology in August 2020, in Europe, age-related macular degeneration (AMD) is the main cause of visual impairment and blindness. About 67 million people in Europe are affected by age-related macular degeneration (AMD). As per the ophthalmic lasers market forecast, the increasing number of individuals with retinal disorders is directly proportional to market growth.
Femtosecond lasers account for the majority of the global market share
The ophthalmic lasers market report has provided a detailed breakup and analysis of the market based on the product. This includes diode lasers, femtosecond lasers, excimer lasers, Nd: YAG lasers, SLT lasers, and others. According to the report, femtosecond lasers account for the majority of the global market share.
Femtosecond lasers are ultrafast laser systems that emit pulses lasting femtoseconds (10^-15 seconds). They find extensive use in various fields, such as ophthalmology for LASIK surgery, where they precisely reshape corneal tissue, leading to improved vision correction outcomes. Furthermore, femtosecond lasers are pivotal in scientific research, facilitating studies on ultrafast phenomena, such as molecular dynamics and quantum interactions. Their unique properties, including high peak power and ultrashort pulses, make them indispensable tools across diverse applications, promising advancements in medicine, technology, and fundamental science.
Refractive error corrections currently exhibit a clear dominance in the market
Ophthalmic lasers play a crucial role in correcting refractive errors, such as myopia, hyperopia, and astigmatism. In procedures like LASIK (Laser-Assisted In Situ Keratomileusis) and PRK (Photorefractive Keratectomy), these lasers reshape the cornea to adjust its focusing power, thereby improving the vision. An article published in the Journal of Annals of Medicine and Surgery in December 2021 indicated that refractive errors are the most common vision problem and prove to be a significant health issue. Similarly, according to the October 2021 press release by the World Health Organization, approximately 88.4 million people suffer blindness due to unaddressed refractive errors. Such rising cases of refractive errors are anticipated to propel the ophthalmic lasers market's recent price in the coming years.
Hospitals hold the largest market share
Hospitals serve as a crucial hub for the adoption and utilization of these advanced technologies. Moreover, hospitals invest in state-of-the-art ophthalmic laser systems to offer cutting-edge treatments for various eye conditions such as cataracts, glaucoma, and refractive errors. Additionally, hospitals provide a platform for ophthalmologists and eye surgeons to perform surgeries and procedures involving ophthalmic lasers, ensuring access to comprehensive eye care for patients. The presence of these advanced technologies in hospitals contributed to improved patient outcomes, enhanced surgical precision, and expanded treatment options in the field of ophthalmology.
North America currently dominates the global market
The rise in the adoption of highly advanced techniques and systems in the manufacturing of ophthalmic lasers and the technological advancements made in ophthalmic lasers are primarily bolstering the growth of the market in the North American region. Moreover, the rising cases of eye disorders in the region are offering lucrative growth opportunities to the market. For instance, a press release published in February 2022 by the Centers for Disease Control and Prevention (CDC) offered prevalence estimates for the most common eye disorders and eye diseases. Nearly 12 million adults in the United States who were 40 years and above of age had vision impairment, with about a million of them being blind. Besides this, the concerned regulatory authorities are also expediting the approval process for laser technologies, which is further creating a positive outlook for the market. For instance, in December 2021, LASEROPTEK Co., Ltd. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PicoLO Premium picosecond pulse Nd: YAG laser. The approvals of such innovative products in the United States are positively impacting the ophthalmic lasers market outlook.